| The target landscape of clinical kinase drugs S Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ... Science 358 (6367), eaan4368, 2017 | 737 | 2017 |
| Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV A Stukalov, V Girault, V Grass, V Bergant, O Karayel, C Urban, DA Haas, ... Biorxiv, 2020 | 586* | 2020 |
| Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ... Nature Communications 11 (1), 1-12, 2020 | 278 | 2020 |
| ProteomicsDB: a multi-omics and multi-organism resource for life science research P Samaras, T Schmidt, M Frejno, S Gessulat, M Reinecke, A Jarzab, ... Nucleic acids research 48 (D1), D1153-D1163, 2020 | 185 | 2020 |
| Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms P Le, E Kunold, R Macsics, K Rox, MC Jennings, I Ugur, M Reinecke, ... Nature Chemistry 12 (2), 145-158, 2020 | 84 | 2020 |
| Decrypting drug actions and protein modifications by dose-and time-resolved proteomics J Zecha, FP Bayer, S Wiechmann, J Woortman, N Berner, J Müller, ... Science 380 (6640), 93-101, 2023 | 24 | 2023 |
| Chemoproteomic selectivity profiling of PIKK and PI3K kinase inhibitors M Reinecke, B Ruprecht, S Poser, S Wiechmann, M Wilhelm, ... ACS chemical biology 14 (4), 655-664, 2019 | 24 | 2019 |
| Adaptive resistance to EGFR-targeted therapy by calcium signaling in NSCLC cells C Mulder, N Prust, S Van Doorn, M Reinecke, B Kuster, ... Molecular Cancer Research 16 (11), 1773-1784, 2018 | 19 | 2018 |
| Kinobeads: A Chemical Proteomic Approach for Kinase Inhibitor Selectivity Profiling and Target Discovery M Reinecke, S Heinzlmeir, M Wilhelm, G Médard, S Klaeger, B Kuster Target Discovery and Validation: Methods and Strategies for Drug Discovery …, 2019 | 11 | 2019 |
| Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors M Reinecke, P Brear, L Vornholz, BT Berger, F Seefried, S Wilhelm, ... Nature Chemical Biology, 1-9, 2023 | 9 | 2023 |
| Optimization of the Lead Compound NVP‐BHG712 as a Colorectal Cancer Inhibitor A Tröster, M DiPrima, N Jores, D Kudlinzki, S Sreeramulu, SL Gande, ... Chemistry–A European Journal 29 (23), e202203967, 2023 | 4 | 2023 |
| CiRCus: a framework to enable classification of complex high-throughput experiments F Seefried, T Schmidt, M Reinecke, S Heinzlmeir, B Kuster, M Wilhelm Journal of proteome research 18 (4), 1486-1493, 2019 | 4 | 2019 |
| Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity V Němec, P Khirsariya, P Janovská, PM Moyano, L Maier, P Procházková, ... Angewandte Chemie 135 (11), e202217532, 2023 | 2 | 2023 |
| Identifying small molecule probes for kinases by chemical proteomics M Reinecke Technische Universität München, 2020 | 2 | 2020 |
| Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv 2020.06. 17.156455 [Preprint]. 17 June 2020 A Stukalov, V Girault, V Grass, V Bergant, O Karayel, C Urban, DA Haas, ... | | |
